Information disclosure in Oracle Life Sciences Central Designer

CVE-2026-21974

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

Vulnerability class: Information Disclosure

EPSS: 0.002 (12.5th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 5.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N.

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2026-21974?
CVE-2026-21974 is a medium-severity vulnerability in Oracle Life Sciences Central Designer, classified under Information Disclosure. CVSS score: 5.3/10. Published 2026-01-20.
How severe is CVE-2026-21974?
Medium severity. CVSS v3 base score is 5.3 out of 10.